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Abstract
Studies of the model plant Arabidopsis thaliana may seem to have little impact on advances in
medical research, yet a survey of the scientific literature shows that this is a misconception. Many
discoveries with direct relevance to human health and disease have been elaborated using
Arabidopsis, and several processes important to human biology are more easily studied in this
versatile model plant.
Arabidopsis thaliana, the reference species for plant biology and a key model system for all
of biology, has had a greater impact on human health research than may seem evident at first
glance. In this Essay, we highlight examples where research using Arabidopsis has informed
the identification of a prototype protein or domain involved in a human disease, human
development, or other important aspects of human biology. These examples do not include
the enormous impact that Arabidopsis research has had on plant biology, improving food
security, and alleviating malnutrition, which is a major threat to human health and is the
basis of 50% of human disease worldwide. We make the case that well-chosen, deep
investment into research using plant genetic models will help to elucidate basic life
processes and to illuminate the evolutionary plasticity of cellular pathways and networks.
The Arabidopsis thaliana genome sequence was completed in 2000. Three years later, with
the reporting of the annotated human genome sequence, it became evident that a majority of
human genes that were suspected or known to play a role in disease had orthologs in
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Arabidopsis (http://mips.gsf.de/proj/thal/db/tables/disease.html). This marked degree of
similarity in “disease genes” is comparable to that observed in other model organisms. For
example, among cancer genes, 70% of genes implicated in cancer have Arabidopsis
orthologs with E-value cutoffs of less than E^10, whereas the percentage of orthologs in the
fruit fly Drosophila melanogaster is 67%, in the worm Caenorhabditis elegans is 72%, and
in the budding yeast Saccharomyces cerevisiae is 41%. In one sense, this high percentage of
shared genes is not surprising given that development and disease follow the normal and
abnormal activities, respectively, of proteins that serve basic cellular functions. But with 1.6
billion years for Arabidopsis and humans to have diverged, is it too much to expect that the
original functions of these gene products survived intact? Are the distinct body plans and
life strategies of humans and plants so different that the respective human and plant
orthologs were not similarly constrained in their evolution and could not conceivably
function in a similar way? We answer “no” to both questions by highlighting several
examples where Arabidopsis research led the way in the discovery or analysis of genes and
processes of importance in human health. Many model systems greatly impacted human
health, and we argue that Arabidopsis is a part of this diversified portfolio of tools needed to
understand basic cellular processes.
Innate Immunity and Intracellular Receptors
Plant NB-LRR proteins (nucleotide-binding site - leucine-rich repeats) are the primary
intracellular receptors of the plant immune system and are encoded by what are historically
termed disease resistance genes (Jones and Dangl, 2006). The first plant NB-LRR genes were
reported in 1994 and 1995. There are ~150 of these genes in Arabidopsis, and their
definition enabled annotation of candidate disease resistance genes in many flowering
plants. Equivalent human orthologous and paralogous genes in the animal innate immune
system are variously called NOD/CARD/CATERPILLAR (Ting et al., 2006).
These proteins are involved in a variety of inflammatory responses. Most importantly,
genetic variation in NOD2, cryopyrin, and CIITA (MHC class II trans-activator) in humans
and Naip5 (neuronal apoptosis inhibitory protein 5) in mice is associated with inflammatory
disease or increased susceptibility to bacterial infections as well as cold-induced auto-
inflammatory syndrome and Mediterranean fever. Mammalian NOD proteins may be
cytosolic sensors for the induction of apoptosis, as well as for innate recognition of
microorganisms and for regulation of inflammatory responses. The first human NOD gene,
CIITA, was isolated in 2000 (Ting et al., 2006), and the connection was made to the NB-LRR
plant disease resistance genes. NOD2 was the first candidate gene cloned for Crohn’s
disease, a severe inflammatory disorder of the small intestine (Hugot et al., 2001). This
candidate gene was identified by virtue of its homology with the plant NB-LRR proteins.
The plant NB-LRR proteins are associated with molecular chaperones that may be required
to “hold and mold” them in a signal-competent manner. The involvement of the cytosolic
HSP90 and SGT1 chaperone proteins in the immune response was first defined in plants,
along with the plant-specific RAR1 protein, which is structurally related to animal p24
(Jones and Dangl, 2006). Animal orthologs of cytosolic HSP90 and SGT1 were
subsequently shown to control NOD/CATERPILLAR function in animal innate immunity
(da Silva Correia et al., 2007; Mayor et al., 2007). The NB-LRR and the NOD/CARD/
CATERPILLAR proteins exist in a complex functional relationship with the Toll-like
receptors (TLRs), which are pattern recognition receptors involved in detection of microbial
pathogens. A distinct set of extracellular pattern recognition receptors operates in the plant
innate immune system. These carry extracellular leucine-rich repeats but use cytosolic
serine-threonine kinase signaling domains instead of Toll/interleukin-1 receptor (TIR)
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domains. Several of these act like animal TLRs to recognize pathogen-associated molecular
patterns (Zipfel et al., 2006).
Light Signaling, Protein Degradation, and Cancer
Plants exhibit considerable phenotypic plasticity as most plant organs do not arise until after
the seed germinates, allowing organ size, shape, and physiology to be optimized to the local
environment throughout their development. Because they are sessile and photosynthetic,
plants are especially attuned to their light environment. Light influences every
developmental transition from seed germination to flowering, with particularly dramatic
effects on the morphogenesis of seedlings. Light signals do not act autonomously but are
integrated with seasonal and diurnal changes in temperature, as well as with intrinsic
developmental programs to specify correct spatial and temporal regulation of gene
expression, organelle development, and cellular differentiation. The diverse responses that
plants have to light provide a unique model system for understanding phenotypic plasticity.
As a result, the study of light signaling in plants has not only provided insight into plant
growth and development but also has led to the discovery of conserved proteins that regulate
transcription, tumorigenesis, and lipid metabolism in metazoans (Yi and Deng, 2005).
Almost 20 years ago, mutant screens for dark-grown seedlings that resemble light-grown
plants led to the discovery of a handful of genes, called DET, COP, and FUS, which based
on genetic experiments encode regulatory proteins that act downstream of multiple
photoreceptors (Chory et al., 1989). Many of these genes were cloned by the early 1990s,
and biochemical studies revealed that most of these proteins played a role in targeted protein
turnover. These proteins were found to be either part of an evolutionarily conserved protein
complex of eight subunits (CSN1-8), called the COP9 signalosome after its prototype
subunit COP9, or part of an E3 ligase called the CDD complex (COP10, DET1, DDB1)
characterized in both plants and animals (Wei and Deng, 2003; Yi and Deng, 2005). The
CDD complex is now the most recently characterized E3 ligase and functions in the light-
regulated development of plants. The best characterized activity of the CSN is its ability to
cleave and remove the ubiquitin-like protein, Nedd8, from cullin ubiquitin ligase subunits (a
process called denedyllation). Neddylation is another process that was elucidated first in
Arabidopsis (see below).
The discovery of light signaling pathway components in plants, such as the COP1 E3 ligase,
the COP9 signalosome, and DET1, boosted our understanding of the effects on gene
expression of the mammalian p53 tumor suppressor (Dornan et al., 2004) and the
transcription factors CREB (Qi et al., 2006) and c-JUN (Wertz et al., 2004). Understanding
of these plant molecules also shed light on T cell homeostasis (Menon et al., 2007) and on
fatty-acid synthetic enzymes in lipid metabolism in animals (Qi et al., 2006). Detailed
biochemical studies of the plant proteins revealed how turnover of the mammalian factors is
regulated. Considerable work in plants elucidated the function of the COP9 signalosome and
COP1, which facilitated research on these proteins in animal cells. Thus, studying light
signaling in plants enabled new avenues of inquiry relevant to mammalian tumorigenesis,
DNA damage, and lipid metabolism.
Cryptochromes and the Circadian Clock
After years searching for a blue-light photoreceptor in plants, Ahmad and Cashmore (1993)
identified a gene that, upon careful scrutiny, encoded a protein that fit the bill. The name
cryptochrome (CRY1) was given because many of the blue-light responses that were used
historically as diagnostics were found in cryptogams, an old term describing non-flowering
plants like ferns, mosses, and algae. Cryptochromes modulate developmental processes,
such as flowering, that are under control of the photoperiod. Many other blue-light responses
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in plants are regulated by another family of blue-light photoreceptors called phytotropins.
Arabidopsis has two cryptochromes, CRY1 and CRY2, prototypes among members of the
larger class found in eukaryotes, which evolved from DNA photolyases. Most plant
cryptochromes contain an amino-terminal photolyase-like domain and a carboxy-terminal
domain, which are important for trafficking of molecules between the nucleus and cytosol.
The carboxy-terminal domain also forms protein-protein interfaces with other
photoreceptors and with the protein degradation machinery (including COP1) to target
specific transcription factors (Li and Yang, 2007).
Among the many developmental phenomena that involve plant cryptochromes is circadian
rhythm. Mammalian CRY homologs were cloned in 1998 by Aziz Sancar’s group (Thresher
et al., 1998). Loss of either the mouse CRY1 or CRY2 gene confers altered (and opposite)
free-running circadian periods. Loss of CRY2 attenuates the light induction of the Per gene,
which encodes a component of the circadian clock (Thresher et al., 1998). CRY1 and CRY2
along with the proteins PER1 and PER2 form the core of the mammalian clock. CRY is
targeted for degradation by an F box protein of an E3 ubiquitin ligase and mutations in this F
box protein extend the circadian period in mice (Virshup and Forger, 2007). These
contributions and other work using the Drosophila CRY and Per gene homologs led to the
conclusion that cryptochromes entrain the circadian clock by interacting with some of the
clock components.
It may not be surprising then that a number of diseases that depend on a functioning
circadian clock are suspected to be caused by defects in the cryptochrome pathway. For
example, altered circadian rhythm is associated with some cancers, although the jury is still
out on whether the circadian defects are causative.
AXR1, The Ubiquitin Cycle, and Alzheimer’s Disease
Auxins are low molecular weight plant hormones that regulate virtually all aspects of plant
development through effects on cell division, elongation, and differentiation. Genetic and
biochemical studies in Arabidopsis showed that auxin regulates gene expression by
promoting the ubiquitin-dependent degradation of transcriptional repressors called Aux/IAA
proteins (Parry and Estelle, 2006). Because the ubiquitin pathway is highly conserved
among eukaryotes, several discoveries in auxin research had important implications for
cellular regulation in animals. The first Arabidopsis protein shown to be required for an
auxin response was AXR1 (Parry and Estelle, 2006). Working simultaneously in both
Arabidopsis and yeast, researchers in the Estelle lab demonstrated that AXR1 is required for
conjugation of a ubiquitin-related protein called RUB1 onto CUL1, a subunit of a ubiquitin
protein ligase (E3 type) called SCF (Parry and Estelle, 2006). Genetic studies in Arabidopsis
indicate that RUB1 modification of CUL1 is essential for SCF activity. One such E3 ligase,
SCFTIR1, targets the Aux/IAAs for degradation (Kepinski, 2007). Subsequent studies in
animal systems demonstrated that the animal ortholog of RUB1, Nedd8, is also required for
SCF function and that the RUB1/Nedd8 conjugation pathway is conserved between plants
and animals (Petroski and Deshaies, 2005). SCFs are involved in many aspects of cell
growth in animals and are implicated in human diseases including cancer (Petroski and
Deshaies, 2005). In addition, altered cullin neddylation is associated with Alzheimer’s
disease. For example, the human protein APP-AB1 binds to amyloid precursor protein
(APP), the source of β-amyloid plaques that accumulate in the brains of patients with
Alzheimer’s disease (Chow et al., 1996). The significance of this interaction is not
completely clear, but recent evidence in Drosophila suggests that APP binding to APP-AB1
reduces cullin neddylation, thus potentially altering the activity of many different SCFs
(Chow et al., 1996; Kim et al., 2007a).
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Given that activity of the ubiquitin pathway, and SCFs in particular, has such an important
role in human disease, there has been extensive research on regulation of SCF-substrate
interactions. For many SCFs, phosphorylation of the substrate is required for binding
(Petroski and Deshaies, 2005). However, in the case of SCFTIR1, substrate recognition is
governed by binding of auxin directly to the F box protein subunit of the SCF (Kepinski,
2007). In a sense, auxin may act like “molecular glue,” stabilizing an interaction between
these two proteins. Thus, work in Arabidopsis introduced an entirely new way of regulating
protein-protein interactions. At this point it is not known if animals use this type of
regulation, but given the conservation of fundamental biochemical processes, it certainly
seems likely.
Argonautes and RNA Silencing
A variety of small regulatory RNAs including small-interfering RNAs (siRNAs),
microRNAs (miRNAs), transacting siRNAs (tasiRNAs), and Piwi-interacting RNAs
(piRNAs) are major regulators of myriad processes in eukaryotic cells through silencing
different classes of genes (Chapman and Carrington, 2007). For example, more than a third
of human protein-coding RNAs appear to be targets of different microRNAs. The Argonaute
proteins, which serve as catalytic components of the RNA-induced silencing complex, are
key regulators of these various RNA-silencing processes and interact directly with the
relevant small RNA to help guide it to its target mRNA. Plant research has made a major
impact on the field of RNA silencing. Some of the first descriptions of homology-dependent
gene silencing phenomena, such as cosuppression and RNA-directed DNA methylation, and
the discovery of siRNAs and of the enzyme Dicer were made in plants (Matzke et al., 2001).
In addition, the first Argonaute gene was cloned from Arabidopsis.
The implications for Argonaute proteins and RNA silencing in human health and disease are
immense. First and foremost, RNA interference (RNAi) may hold promise for treating a
diverse array of human diseases including age-related macular degeneration, Alzheimer’s
disease, and arthritis (Kim and Rossi, 2007). RNAi is under development for
downregulating viruses such as the hepatitis B virus, HIV, and respiratory syncytial virus, as
well as oncogenes important in tumorigenesis. RNAi has proved invaluable for studying the
loss of gene function in mammalian systems, speeding along basic research and allowing the
rapid development of animal models in which disease genes are silenced by RNAi (Kim and
Rossi, 2007). Finally, misregulation of microRNAs is associated with a variety of clinically
important diseases and cancers, and Argonaute proteins themselves have been linked to
disorders such as fragile X syndrome and some forms of autoimmune disease.
DNA Methylation
Cytosine DNA methylation is an epigenetic mark for gene silencing that is important in
many gene regulatory systems including genomic imprinting, X chromosome inactivation,
and the silencing of transposons and other DNA sequences containing either direct or
inverted repeats. Despite the importance of DNA methylation and decades of
phenomenological descriptions of epigenetic regulatory systems (Chan et al., 2005; Goll and
Bestor, 2005), genetic studies of the mechanisms regulating DNA methylation are still
underdeveloped. In part, this reflects the fact that although methylation is present in most
eukaryotes, it was curiously lost in several well-studied model organisms such as baker’s
yeast and C. elegans. Arabidopsis is arguably one of the best organisms for genetic studies
of DNA methylation because it has much in common with mammalian systems, having
orthologs of the two major human DNA methyltransferases, Dnmt1 and Dnmt3.
Furthermore, unlike the mouse where DNA methylation mutants are not viable, Arabidopsis
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tolerates mutations that virtually eliminate methylation, thus allowing detailed genetic
analyses (Chan et al., 2005).
Several discoveries concerning DNA methylation were made first in Arabidopsis and were
later translated to mammalian systems. For instance, the chromatin remodeling factor
DECREASE IN DNA METHYLATION 1 (DDM1) was first discovered in screens for
Arabidopsis mutants with loss of centromeric methylation (Chan et al., 2005; Goll and
Bestor, 2005). Only later was the mammalian ortholog LSH shown to have the same effect.
A second example is the relationship between histone methylation and DNA methylation,
which was initially described in fungi and Arabidopsis and only subsequently in mammalian
systems (Chan et al., 2005; Goll and Bestor, 2005). A third example is the function of an
accessory factor for Dnmt1, UHRF1. Its ortholog, VIM1/ORTH2 was first shown in plant
systems to be required for the maintenance of CG DNA methylation. A key domain in this
protein, the SRA domain, binds directly to methylated DNA, giving clues to its mechanism
of action. These early findings paved the way for functional studies of mouse and human
UHRF1 showing it to be a critical cofactor that binds to hemimethylated DNA and directly
recruits the maintenance DNA methyltransferase Dnmt1 (Ooi and Bestor, 2008).
Evidence for a role of DNA methylation in human health and disease is overwhelming.
Mutations in the human DNA methyltransferase gene Dnmt3b are the cause of ICF
syndrome (immunodeficiency, centromeric instability, and facial anomalies), and mutations
affecting the methyl DNA-binding domain protein MeCP2 cause Rett syndrome, a
childhood neurodevelopmental disorder (Goll and Bestor, 2005). Furthermore, it is
increasingly clear that epigenetic mutations, in the form of heritable hypermethylation or
hypomethylation of particular tumor suppressor genes or oncogenes, are a major contributor
to cancer (Jones and Baylin, 2007).
Leucine-Rich Receptor Kinases, Ion Transport, and G Protein Signaling
Studies of Arabidopsis also changed the direction of mammalian research in other ways,
even when the prototype gene for a particular function or process may have been observed
first in another model system. For example, the finding of Shaker-like potassium channels in
Arabidopsis (Rodriguez-Navarro and Rubio, 2006) advanced research into potassium fluxes
in renal (Wang, 2004) and heart (Schwartz, 2005) disease. The discovery of nitrate
transporters in Arabidopsis (Tsay et al., 1993) led to the identification of peptide transporters
in yeast and mammals. Leucine-rich serine/threonine kinase receptors were first discovered
in Arabidopsis (Chang et al., 1992). One member of the leucine-rich receptor kinase
subfamily identified in humans, LRRK2, is genetically associated with Parkinson’s disease
(Mata et al., 2006).
Considering the maturity of the field of heterotrimeric G protein signaling, it is hard to
imagine how another model system could make an impact, but breakthroughs in G protein
research in Arabidopsis have done just that. No other multicellular model system has a G
protein repertoire as simple as that of Arabidopsis (Temple and Jones, 2007). Plants and
animals diverged from an ancestral cell 1.6 billion years ago, suggesting that much can be
learned from studying the similarities and differences in their molecular properties (Johnston
et al., 2007). Indeed, comparative genomic and proteomic studies have opened up new
research avenues. An excellent example is the comparison of the proteomic profiles of
Arabidopsis (which does not have centrioles) and the single-celled alga Chlamydomonas
(which does), yielding several new basal body proteins in humans (Li et al., 2004).
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Natural Genetic Variation
The main focus of human genetics is currently the role that heritable differences play in
disease susceptibility and the response to drugs. For natural genetic variation, Arabidopsis is
arguably the best model organism available. The species grows naturally under a wide range
of environmental conditions throughout much of the Northern hemisphere. Because it is
self-fertile, locally adapted lines collected from the wild are naturally inbred. This in turn
enables repeated phenotyping of the same genotypes under diverse controlled conditions,
making Arabidopsis extremely well suited for studying genotype-environment interactions,
a problem of direct importance to the human genetics community.
Natural alleles that affect performance in the wild have been identified for many traits, a
prominent example being the FRIGIDA gene controlling flowering (Johanson et al., 2000).
An important question, which was central for designing human association mapping studies,
is whether common genetic syndromes are caused by just a few high-frequency alleles or by
many rare alleles. Arabidopsis provides examples of both—indeed, the FRIGIDA work
nicely showed that common and rare alleles with the same phenotypic effect can be found at
the same locus.
The self-fertilizing habit of Arabidopsis makes genome-wide association studies extremely
cost effective. Unlike human case-control studies, it is possible to genotype once and then
phenotype many times under a huge variety of conditions. Arabidopsis now has a larger
genomic polymorphism database than any other nonhuman organism. For example, a
250,000 SNP-chip for genome-wide association studies is currently being used to genotype
over 1,000 wild strains (Kim et al., 2007b) (http://walnut.usc.edu/2010). Given that the
extent of linkage disequilibrium is comparable to that in humans, coverage of the genome is
likely better for Arabidopsis because of its smaller genome. Similarly, filling in between the
HapMap tag-SNPs will be much more straightforward, and efforts to accomplish this are
under way. The genetic variation resource can be easily complemented by whole-genome
epigenomic information. Arabidopsis is thus likely to lead the way in the endeavor to
productively combine the most important current trends in medical research: genetic
diversity and systems biology.
Diversifying Our Portfolio
In addition to the discoveries described here, it is worth mentioning some of the earlier
examples of fundamental findings made first in plants that have turned out to be critical for
our understanding of human biology: cells, nuclei, genes, molecular chaperones, viruses,
transposable elements, programmed cell death, and gaseous hormones. As the predominant
plant model system, Arabidopsis has followed in this tradition. It has proven to be the
reference plant for translational work on agricultural improvements, and even as a relative
newcomer on the “genetic model” block, it has shown its mettle in eukaryotic research, with
clear examples of how Arabidopsis research has impacted human health. The trend will
continue, and we expect that soon Arabidopsis will be universally recognized and
appreciated as part of the diverse portfolio used in human health research.
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